Health Reform and Drug Financing. Selected Topics - Health Economics and Drugs Series, No. 006
(1998; 49 pages) [French] [Spanish]
Table of Contents
View the documentAcknowledgements
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Financing reforms
Open this folder and view contents3. Affordability and efficiency
Close this folder4. Organizational reforms
View the document4.1 Competitive mechanisms in public drug supply
View the document4.2 Decentralization in drug supply systems
View the document4.3 Role of the “third sector”
View the documentConclusions
View the documentReferences
View the documentBack Cover

4. Organizational reforms

Reforms to financing systems cannot be made without organizational reforms that should match the structure of the public and private sectors to their responsibilities in fulfilling policy objectives. The changes can include transformations within ministries of health, the decentralization of health service provision, the incorporation of competitive mechanisms within the public sector, and enhanced roles for the private for-profit and private not-for-profit sectors.

to previous section
to next section
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: December 6, 2017